Growth Metrics

Catalyst Pharmaceuticals (CPRX) Enterprise Value Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -72.11%
Dec 31, 2025 -33.45%
Sep 30, 2025 -39.15%
Jun 30, 2025 -43.53%
Mar 31, 2025 -43.19%
Dec 31, 2024 -39.35%
Sep 30, 2024 -36.27%
Jun 30, 2024 -34.25%
Mar 31, 2024 -29.39%
Dec 31, 2023 0.63%
Sep 30, 2023 1.64%
Jun 30, 2023 -15.83%
Mar 31, 2023 -13.37%
Dec 31, 2022 -46.70%
Sep 30, 2022 -49.56%
Jun 30, 2022 -54.45%
Mar 31, 2022 -63.05%
Dec 31, 2021 -52.93%
Sep 30, 2021 -41.52%
Jun 30, 2021 -31.42%
Mar 31, 2021 -22.51%
Dec 31, 2020 -18.64%
Sep 30, 2020 -55.35%
Jun 30, 2020 -48.50%
Mar 31, 2020 -40.70%
Dec 31, 2019 -32.75%
Sep 30, 2019 -61.40%
Jun 30, 2019 -9.81%
Mar 31, 2019 -20.71%
Dec 31, 2018 -18.73%
Sep 30, 2018 -19.14%
Jun 30, 2018 -18.67%
Mar 31, 2018 -20.06%
Dec 31, 2017 -33.19%
Sep 30, 2017 3.50%
Jun 30, 2017 -23.80%
Mar 31, 2017 -96.89%
Dec 31, 2016 -27.06%
Sep 30, 2016 8.34%
Jun 30, 2016 -83.19%
Mar 31, 2016 -242.45%
Dec 31, 2015 -53.04%
Sep 30, 2015 -44.95%
Jun 30, 2015 -75.96%
Mar 31, 2015 -112.06%
Dec 31, 2014 -80.68%
Sep 30, 2014 -108.63%
Jun 30, 2014 -50.72%
Mar 31, 2014 11.37%
Dec 31, 2013 -53.23%
Sep 30, 2013 -55.83%